Saturday, January 31, 2026

Japanese Olympians Under Fire: JOC’s Rare Response to Online Hate and What It Means

The JOC has taken the rare step of mulling over legal action against malicious comments and criticism directed at athletes in the Olympics.

JW Pharmaceutical Secures U.S. Patent for Hair Loss Drug Candidate JW0061

JW Pharmaceutical secures a U.S. patent for hair loss treatment JW0061, targeting GFRA1 receptor, ensuring market exclusivity until 2039.

Jennie’s ‘Love Hangover’ Lands on Billboard Hot 100, Marks Highest Solo Debut

BLACKPINK's Jennie achieves Billboard milestone with "Love Hangover," leading to anticipation for her debut album, Ruby, and upcoming tour.

Tag: acquisitions

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Eli Lilly vs. Novo Nordisk: A $1.2 Billion Bet Reveals Two Very Different Futures for Obesity Drugs

Eli Lilly and Novo Nordisk are pursuing different strategies in the obesity treatment market, focusing on expansion versus core strengths.

Big Pharma Braces for $300 Billion Loss as Blockbuster Drug Patents Expire

Global pharma faces $300B losses from patent expirations, prompting a shift to multi-indication drugs and innovative therapies.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.